VEGFA and pulmonary arterial hypertension: In this context, the effects do not reflect the enhanced antiangiogenic properties but rather appear to be almost unexpected and, at first glance, counterintuitive, raising further concerns about the heterogeneous role of VEGF in the pathogenesis of PAH.